Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the anti-tumor efficacy of tadalafil in
combination with Lenalidomide/dexamethasone (Rd) in multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins